HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew P Morrow Selected Research

Liver X Receptors

8/2010Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew P Morrow Research Topics

Disease

10Infections
01/2023 - 08/2010
9Neoplasms (Cancer)
12/2023 - 10/2012
5HIV Infections (HIV Infection)
03/2015 - 10/2006
3Injection Site Reaction
01/2023 - 11/2015
3Uterine Cervical Dysplasia
01/2018 - 10/2012
2Papillomavirus Infections
12/2023 - 03/2013
2Recurrent respiratory papillomatosis
11/2023 - 01/2020
2Hepatitis C
01/2023 - 12/2011
2Human Influenza (Influenza)
01/2018 - 05/2014
2Communicable Diseases (Infectious Diseases)
08/2015 - 10/2010
2Dyslipidemias (Dyslipidemia)
08/2010 - 10/2006
1Chronic Hepatitis C
01/2023
1Viremia
01/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1COVID-19
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2019
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2019
1Pneumonia (Pneumonitis)
01/2017
1Weight Loss (Weight Reduction)
01/2016
1Zika Virus Infection
01/2016
1Erythema
11/2015
1Tuberculosis (Tuberculoses)
08/2015
1Breakthrough Infections
01/2015
1Emerging Communicable Diseases (Emerging Infectious Diseases)
05/2014
1Pain (Aches)
10/2012
1Virus Diseases (Viral Diseases)
10/2010
1Cardiovascular Diseases (Cardiovascular Disease)
08/2010
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2006
1Atherosclerosis
10/2006
1Lipodystrophy
10/2006

Drug/Important Bio-Agent (IBA)

13VaccinesIBA
12/2023 - 10/2010
6DNA VaccinesIBA
01/2023 - 09/2011
6AntigensIBA
01/2021 - 12/2011
4Proteins (Proteins, Gene)FDA Link
01/2023 - 03/2009
4DNA (Deoxyribonucleic Acid)IBA
01/2023 - 10/2012
2Interleukin-12 (IL 12)IBA
01/2023 - 01/2021
2CytokinesIBA
01/2023 - 10/2010
2Viral AntigensIBA
01/2023 - 03/2013
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021 - 09/2013
2VGX-3100IBA
01/2018 - 11/2015
2InterferonsIBA
01/2016 - 10/2012
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
08/2015 - 03/2014
2Interleukin-33IBA
08/2015 - 03/2014
2CholesterolIBA
08/2010 - 10/2006
1A-Form DNA (A-DNA)IBA
11/2023
1Granzymes (Granzyme)IBA
01/2021
1PerforinIBA
01/2021
1AntibodiesIBA
01/2019
1MEDI0457IBA
01/2019
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Formaldehyde (Formol)FDA Link
01/2017
1Respiratory Syncytial Virus VaccinesIBA
01/2017
1HLA-DR Antigens (HLA-DR)IBA
01/2015
1CC ChemokinesIBA
01/2015
1Hemagglutinins (Hemagglutinin)IBA
05/2014
1Glycoproteins (Glycoprotein)IBA
05/2014
1AlarminsIBA
03/2014
1EnzymesIBA
10/2012
1Nucleocapsid ProteinsIBA
09/2011
1Adenosine Triphosphate (ATP)IBA
08/2010
1HDL LipoproteinsIBA
08/2010
1LigandsIBA
08/2010
1BenzenesulfonamidesIBA
08/2010
1Liver X ReceptorsIBA
08/2010
1vpr Gene ProductsIBA
03/2009
1Lipoproteins (Lipoprotein)IBA
10/2006
1Apolipoprotein A-I (Apolipoprotein A1)IBA
10/2006
1Anti-HIV Agents (AIDS Drugs)IBA
10/2006
1LipidsIBA
10/2006

Therapy/Procedure

7Immunotherapy
11/2023 - 03/2013
6Therapeutics
01/2020 - 08/2010